SCHEMBL20094580

SCHEMBL20094580

CC(=O)OC12CCC(OC(C)=O)(CC1)CC2

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
EP300 Q09472 1/20 0.36
HIF1A Q16665 1/20 0.36
CREBBP Q92793 1/20 0.36
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 2/20 0.30
LMNA P02545 2/20 0.30
TDP1 Q9NUW8 1/20 0.30
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20898647 0.89 EP300 (0.33) ALDH1A1TSHREP300HIF1ACREBBP
SCHEMBL30751154 0.82 EP300 (0.38) EP300HIF1ACREBBPALOX15
SCHEMBL11062782 0.81 ALDH1A1 (0.37) ALDH1A1TSHREP300HIF1ACREBBP
Acetic Acid SCHEMBL11446893 0.78 EP300 (0.40) EP300HIF1ACREBBPALOX15FFAR3
SCHEMBL14885140 0.73 GAA (0.33) EP300HIF1ACREBBP
SCHEMBL4178823 0.73 EP300 (0.40) EP300HIF1ACREBBPALOX15
SCHEMBL27869033 0.73
SCHEMBL1287801 0.73
SCHEMBL6092390 0.73
SCHEMBL5607821 0.73 ALDH1A1 (0.30) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109152-A1 PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL EASTMAN CHEMICAL COMPANY (US) 2025-04-03 US disclosed
CN-114585629-B Process for preparing bicyclo [2.2.2] octane-1, 4-diol 伊士曼化工公司 2024-10-01 CN disclosed
US-20240010661-A1 PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL EASTMAN CHEMICAL COMPANY (US) 2024-01-11 US disclosed
CN-111433181-B Synthesis of bicyclo [2.2.2] octane derivatives 伊士曼化工公司 2023-08-04 CN disclosed
US-11518726-B2 Synthesis of bicyclo[2.2.2]octane derivatives EASTMAN CHEMICAL COMPANY (US) 2022-12-06 US disclosed
US-11518726-B2 Synthesis of bicyclo[2.2.2]octane derivatives EASTMAN CHEMICAL COMPANY (US) 2022-12-06 US disclosed
EP-4055024-A1 PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL Eastman Chemical Company (US) 2022-09-14 EP disclosed
CN-109843846-B Synthesis of bicyclo [2.2.2] octane 伊士曼化工公司 2022-07-05 CN disclosed
CN-114585629-A Method for producing bicyclo [2.2.2] octane-1, 4-diol 伊士曼化工公司 2022-06-03 CN disclosed
EP-3529230-B1 SYNTHESIS OF BICYCLO(2.2.2)OCTANES EASTMAN CHEM CO (US) 2020-09-30 EP disclosed
EP-3529230-B1 SYNTHESIS OF BICYCLO(2.2.2)OCTANES EASTMAN CHEM CO (US) 2020-09-30 EP disclosed
US-20200270191-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES EASTMAN CHEMICAL COMPANY (US) 2020-08-27 US disclosed
US-20200270191-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES EASTMAN CHEMICAL COMPANY (US) 2020-08-27 US disclosed
US-10633315-B2 Synthesis of bicyclo[2.2.2]octanes EASTMAN CHEMICAL COMPANY (US) 2020-04-28 US disclosed
US-10633315-B2 Synthesis of bicyclo[2.2.2]octanes EASTMAN CHEMICAL COMPANY (US) 2020-04-28 US disclosed
US-20200039906-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANES EASTMAN CHEMICAL COMPANY (US) 2020-02-06 US disclosed
US-20200039906-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANES EASTMAN CHEMICAL COMPANY (US) 2020-02-06 US disclosed
WO-2019075004-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES EASTMAN CHEMICAL COMPANY (US) 2019-04-18 WO disclosed
WO-2018075301-A1 SYNTHESIS OF BICYCLO(2.2.2)OCTANES EASTMAN CHEMICAL COMPANY (US) 2018-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200039906-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANES PPOX, ODC1, AOC2 ALDH1A1 811/4885TSHR 3951/4885EP300 2376/4885
US-10633315-B2 Synthesis of bicyclo[2.2.2]octanes PPOX, ODC1, AOC2 ALDH1A1 811/4885TSHR 3951/4885EP300 2376/4885
US-20200270191-A1 SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES SCO2, AOC2, ODC1 ALDH1A1 1042/4885TSHR 4297/4885EP300 3239/4885
US-11518726-B2 Synthesis of bicyclo[2.2.2]octane derivatives SCO2, AOC2, ODC1 ALDH1A1 1042/4885TSHR 4297/4885EP300 3239/4885
US-20240010661-A1 PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL DCLK1, DCLK2, SBK1 ALDH1A1 3141/4885TSHR 2285/4885EP300 2605/4885
US-20250109152-A1 PROCESS FOR PREPARING BICYCLO[2.2.2]OCTANE-1,4-DIOL DCLK1, DCLK2, SBK1 ALDH1A1 3086/4885TSHR 2298/4885EP300 2707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.